Form 4: Saba Capital Management Reduces Stake in BlackRock Capital Allocation Term Trust

Saba Capital Management, a 10% owner and director, decreased its holdings in BlackRock Capital Allocation Term Trust (BCAT) through recent stock sales.

Summary

• Saba Capital Management, L.P., along with director Boaz Weinstein, reported changes in their beneficial ownership of BlackRock Capital Allocation Term Trust (BCAT) shares.
• On February 6, 2025, Saba Capital Management sold 23,059 shares of common stock at a price of $15.68 per share.
• Following this transaction, Saba Capital Management indirectly owns 13,276,509 shares.
• On February 7, 2025, Saba Capital Management sold 57,230 shares of common stock at a price of $15.62 per share.
• After this second transaction, Saba Capital Management indirectly owns 13,219,279 shares.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative as a large shareholder is reducing their position. This could be interpreted negatively by the market.

Negatives

• Saba Capital Management reduced its stake in BlackRock Capital Allocation Term Trust.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or significant shareholders of a publicly traded company buy or sell the company's stock. These filings provide transparency into the transactions of those with privileged information.

Stakeholder Impact

• Shareholders may react to the news of Saba Capital Management reducing its stake in BCAT.

Key Dates

Keywords

BCAT, BlackRock Capital Allocation Term Trust, Saba Capital Management, Boaz Weinstein, Beneficial Ownership, Stock Sale, Form 4